IL17A and infection: As previously reported, there were no differences in growth nor any significant differences in the frequency of infections, episodes of fever, days with fever, or adverse events between the SF and MFGM groups [10] thereby demonstrating that the observed differences in IL-17A concentrations did not increase infection risk.